BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Hamaguchi M, Takeda N, Kojima T, Ohbora A, Kato T, Sarui H, Fukui M, Nagata C, Takeda J. Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. World J Gastroenterol 2012; 18(13): 1508-1516 [PMID: 22509083 DOI: 10.3748/wjg.v18.i13.1508]
URL: https://www.wjgnet.com/1007-9327/full/v18/i13/1508.htm
(0) (0) (7784) (82)
Number Citing Articles
1
Patrick Wainwright, Christopher Byrne. Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome. International Journal of Molecular Sciences 2016; 17(3) doi: 10.3390/ijms17030367
2
Jong Hwa Choi, Won Sohn, Yong Kyun Cho. The effect of moderate alcohol drinking in nonalcoholic fatty liver disease. Clinical and Molecular Hepatology 2020; 26(4) doi: 10.3350/cmh.2020.0163
3
Varanasi Yugandar Bhargav, Mayank Jain, Tom Alen, Chandan Kumar Kedarisetty, Preetam Arthur, Mu Karthikeyan, Thamarai S. Selvan, Jayanthi Venkataraman. Clusters and Components of Metabolic Syndrome (MeS) as a Predictor for Fatty Liver. Journal of Diabetology 2021; 12(4) doi: 10.4103/jod.jod_17_21
4
Mehmet Emre Atabek, Beray Selver Eklioglu, Nesibe Akyürek. Which metabolic syndrome criteria best predict non-alcoholic fatty liver disease in children?. Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity 2014; 19(4) doi: 10.1007/s40519-014-0129-0
5
Kinuko Uno, Katsuhiro Miyajima, Marika Matsumoto, Marika Toma, Noriko Suzuki-Kemuriyama, Dai Nakae. Influence of <i>trans</i>-fatty acids on non-alcoholic steatohepatitis with hepatic fibrosis induced by a choline-deficient, methionine-lowered, L-amino acid-defined diet in male Harlan Sprague Dawley rats. Fundamental Toxicological Sciences 2021; 8(7) doi: 10.2131/fts.8.221
6
Christopher Leung, Sern Wei Yeoh, Desmond Patrick, Shara Ket, Kaye Marion, Paul Gow, Peter W Angus. Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease. World Journal of Gastroenterology 2015; 21(4): 1189-1196 doi: 10.3748/wjg.v21.i4.1189
7
D. T. Reid, B. Eksteen. Murine models provide insight to the development of non-alcoholic fatty liver disease. Nutrition Research Reviews 2015; 28(2) doi: 10.1017/S0954422415000128
8
Zobair M. Younossi, Munkhzul Otgonsuren, Chapy Venkatesan, Alita Mishra. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. Metabolism 2013; 62(3) doi: 10.1016/j.metabol.2012.08.005
9
Harry G. Preuss. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome. 2018;  doi: 10.1016/B978-0-12-812019-4.00018-0
10
Hamta Taheri Sarvetamin. Determining Breast Density in Patients with Metabolic Syndrome: A Cross Sectional Study. Journal of Pharmacy and Bioallied Sciences 2025; 17(Suppl 1) doi: 10.4103/jpbs.jpbs_1954_24
11
Katsutoshi Tokushige, Kenichi Ikejima, Masafumi Ono, Yuichiro Eguchi, Yoshihiro Kamada, Yoshito Itoh, Norio Akuta, Masato Yoneda, Motoh Iwasa, Masashi Yoneda, Motoyuki Otsuka, Nobuharu Tamaki, Tomomi Kogiso, Hiroto Miwa, Kazuaki Chayama, Nobuyuki Enomoto, Tooru Shimosegawa, Tetsuo Takehara, Kazuhiko Koike. Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. Hepatology Research 2021; 51(10) doi: 10.1111/hepr.13688
12
Yongyuan Zhang, Tao Zhang, Chengqi Zhang, Fang Tang, Nvjuan Zhong, Hongkai Li, Xinhong Song, Haiyan Lin, Yanxun Liu, Fuzhong Xue. Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population. BMJ Open 2015; 5(9) doi: 10.1136/bmjopen-2015-008204
13
Atoosa Adibi, Majid Jaberzadeh-Ansari, Amir-Reza Dalili, Navid Omidifar, Masoumeh Sadeghi. Association between Nonalcoholic Fatty Liver Disease (NAFLD) and Coronary Artery Disease (CAD) in Patients with Angina Pectoris. Open Journal of Medical Imaging 2013; 3(03) doi: 10.4236/ojmi.2013.33015
14
Ryoichi Goto, Norio Kawamura, Masaaki Watanabe, Yoshikazu Ganchiku, Akihisa Nagatsu, Kazufumi Okada, Yoichi M. Ito, Toshiya Kamiyama, Tsuyoshi Shimamura, Akinobu Taketomi. Long‐term risk of a fatty liver in liver donors. Annals of Gastroenterological Surgery 2023; 7(4) doi: 10.1002/ags3.12658
15
Hongyun Lu, Hong Liu, Fang Hu, Lingling Zou, Shunkui Luo, Liao Sun. Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis. International Journal of Endocrinology 2013; 2013 doi: 10.1155/2013/124958
16
Shahinul Alam, Sheikh Mohammad Noor-E-Alam, Ziaur Rahman Chowdhury, Mahabubul Alam, Jahangir Kabir. Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh. World Journal of Hepatology 2013; 5(5): 281-287 doi: 10.4254/wjh.v5.i5.281
17
D. T. Reid, J. L. Reyes, B. A. McDonald, T. Vo, R. A. Reimer, B. Eksteen, Pavel Strnad. Kupffer Cells Undergo Fundamental Changes during the Development of Experimental NASH and Are Critical in Initiating Liver Damage and Inflammation. PLOS ONE 2016; 11(7) doi: 10.1371/journal.pone.0159524
18
Masahide Hamaguchi, Akihiro Obora, Takuro Okamura, Yoshitaka Hashimoto, Takao Kojima, Michiaki Fukui. Changes in metabolic complications in patients with alcoholic fatty liver disease monitored over two decades: NAGALA study. BMJ Open Gastroenterology 2020; 7(1) doi: 10.1136/bmjgast-2019-000359
19
Alan Eduardo Botello-Manilla, Guillermo Nahúm López-Sánchez, Norberto Carlos Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Hepatic steatosis and respiratory diseases: a new panorama. Annals of Hepatology 2021; 24 doi: 10.1016/j.aohep.2021.100320
20
Peng Zhang, Jinfeng Ma, Daojing Li, Qiuhua Li, Ziyou Qi, Peng Xu, Lixia Liu, Hongfang Li, Aimei Zhang. The Role of Remnant Cholesterol Beyond Low-Density Lipoprotein Cholesterol in Arterial Stiffness: A Cross-Sectional Study. Metabolic Syndrome and Related Disorders 2023; 21(9) doi: 10.1089/met.2023.0101
21
Amedeo Lonardo, Stefano Ballestri, Giulio Marchesini, Paul Angulo, Paola Loria. Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome. Digestive and Liver Disease 2015; 47(3) doi: 10.1016/j.dld.2014.09.020
22
Long Wang, Fu Zhi, Beibei Gao, Jie Ni, Yihai Liu, Xuming Mo, Jinyu Huang. Association between lipid profiles and arterial stiffness: A secondary analysis based on a cross-sectional study. Journal of International Medical Research 2020; 48(7) doi: 10.1177/0300060520938188
23
Kohei Oda, Hirofumi Uto, Seiichi Mawatari, Akio Ido. Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies. Clinical Journal of Gastroenterology 2015; 8(1) doi: 10.1007/s12328-014-0548-5
24
Takuro Okamura, Yoshitaka Hashimoto, Masahide Hamaguchi, Akihiro Obora, Takao Kojima, Michiaki Fukui. Low urine pH is a risk for non-alcoholic fatty liver disease: A population-based longitudinal study. Clinics and Research in Hepatology and Gastroenterology 2018; 42(6) doi: 10.1016/j.clinre.2018.06.005
25
Mervat S. Taha, Emad. M. El-Sherbiny, Hala. F. Osman. Anti-ulcerogenic activity of Gum Arabic in gastric mucosal injury induced by ethanol in male albino rats. Applied Physiology, Nutrition, and Metabolism 2020; 45(7) doi: 10.1139/apnm-2018-0233
26
Tao Zhang, Chengqi Zhang, Yongyuan Zhang, Fang Tang, Hongkai Li, Qian Zhang, Haiyan Lin, Shuo Wu, Yanxun Liu, Fuzhong Xue. Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: A prospective cohort study. Atherosclerosis 2015; 240(1) doi: 10.1016/j.atherosclerosis.2015.02.049
27
Mi Kyung Shin, Soo-Man Yang, In-Seob Han. Capsaicin suppresses liver fat accumulation in high-fat diet-induced NAFLD mice. Animal Cells and Systems 2020; 24(4) doi: 10.1080/19768354.2020.1810771
28
Harry G. Preuss, Gilbert R. Kaats, Nate Mrvichin, Debasis Bagchi, Jeffrey M. Preuss. Circulating ALT Levels in Healthy Volunteers Over Life-Span: Assessing Aging Paradox and Nutritional Implications. Journal of the American College of Nutrition 2019; 38(8) doi: 10.1080/07315724.2019.1580169
29
Yoshihiro Kamada, Hirokazu Takahashi, Yuji Ogawa, Hideyuki Hyogo, Kyoko Nakamura, Tomomi Yada, Norihiko Asada, Tomomi Bando, Hanako Sawano, Mika Hatanaka, Takako Tosa, Mika Ando, Etsuko Hikita, Kaori Yoshida, Masahiro Koseki, Yoshio Sumida, Kazuhisa Maeda, Makoto Fujii, Shinichi Aishima, Mariko Hayakawa, Atsushi Nakajima. Characterization of Nutrient Intake in Biopsy-Confirmed NAFLD Patients. Nutrients 2022; 14(17) doi: 10.3390/nu14173453
30
Takuro Okamura, Yoshitaka Hashimoto, Masahide Hamaguchi, Akihiro Obora, Takao Kojima, Michiaki Fukui. Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01809-2
31
Yuka Hasegawa, Hiroshi Okada, Hanako Nakajima, Nobuko Kitagawa, Takuro Okamura, Saori Majima, Takafumi Senmaru, Emi Ushigome, Naoko Nakanishi, Yuki Nakahata, Akihiro Obora, Takao Kojima, Masahide Hamaguchi, Michiaki Fukui. Effects of weight loss on metabolic dysfunction‐associated fatty liver disease in Japanese people: Non‐alcoholic fatty liver disease in the Gifu area, longitudinal analysis study. Hepatology Research 2024; 54(4) doi: 10.1111/hepr.13989
32
Inês Correia‐Sá, Hugo de‐Sousa‐Lopes, Maria J. Martins, Isabel Azevedo, Eduardo Moura, Maria A. Vieira‐Coelho. Effects of raftilose on serum biochemistry and liver morphology in rats fed with normal or high‐fat diet. Molecular Nutrition & Food Research 2013; 57(8) doi: 10.1002/mnfr.201200693
33
Amjad M. Ahmed, Mohamed E. Ebid, Amr M. Ajlan, Mouaz H. Al-Mallah. Low-dose attenuation correction in diagnosis of non-alcoholic fatty liver disease. Abdominal Radiology 2017; 42(10) doi: 10.1007/s00261-017-1166-8
34
Ramanujam Vendhan, Anandakumar Amutha, Ranjit Mohan Anjana, Ranjit Unnikrishnan, Mohan Deepa, Viswanathan Mohan. Comparison of Characteristics Between Nonobese and Overweight/Obese Subjects with Nonalcoholic Fatty Liver Disease in a South Indian Population. Diabetes Technology & Therapeutics 2014; 16(1) doi: 10.1089/dia.2013.0165
35
Daisuke Yoshimaru. 6. Methods of Abdominal MR Spectroscopy and Future Prospects. Japanese Journal of Radiological Technology 2022; 78(2) doi: 10.6009/jjrt.780214
36
Zhenwei Wang, Min Li, Jing Xie, Jing Gong, Naifeng Liu. Association between remnant cholesterol and arterial stiffness: A secondary analysis based on a cross‐sectional study. The Journal of Clinical Hypertension 2022; 24(1) doi: 10.1111/jch.14384
37
Pegah Golabi, Munkhzul Otgonsuren, Rebecca Cable, Sean Felix, Aaron Koenig, Mehmet Sayiner, Zobair M. Younossi. Non-alcoholic Fatty Liver Disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL). Health and Quality of Life Outcomes 2016; 14(1) doi: 10.1186/s12955-016-0420-z
38
Bungo Shirouchi. Regulation of Lipid Metabolism with Dietary Phospholipids. Nippon Eiyo Shokuryo Gakkaishi 2019; 72(6) doi: 10.4327/jsnfs.72.247
39
Katsutoshi Tokushige, Kenichi Ikejima, Masafumi Ono, Yuichiro Eguchi, Yoshihiro Kamada, Yoshito Itoh, Norio Akuta, Masato Yoneda, Motoh Iwasa, Masashi Yoneda, Motoyuki Otsuka, Nobuharu Tamaki, Tomomi Kogiso, Hiroto Miwa, Kazuaki Chayama, Nobuyuki Enomoto, Tooru Shimosegawa, Tetsuo Takehara, Kazuhiko Koike. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. Journal of Gastroenterology 2021; 56(11) doi: 10.1007/s00535-021-01796-x
40
Carmine Finelli, Giovanni Tarantino. Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?. Hepatology International 2013; 7(2) doi: 10.1007/s12072-012-9406-z
41
Yin-Yin Liao, Chih-Kuang Yeh, Kuo-Chin Huang, Po-Hsiang Tsui, Kuen-Cheh Yang. Metabolic Characteristics of a Novel Ultrasound Quantitative Diagnostic Index for Nonalcoholic Fatty Liver Disease. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-44453-3
42
Shu-chao Pang, Shuo Wang, Mei-ling Chen, Jun-ping Zhang, Yuan-yuan Wang, Hui-yun Jia, Li-yuan Bi, Hui Wang. BuShenKangShuai Tablet Alleviates Hepatic Steatosis via Improving Liver Adiponectin Resistance in ApoE-/- Mice. Evidence-Based Complementary and Alternative Medicine 2019; 2019 doi: 10.1155/2019/8986038
43
Takuya Fukuda, Masahide Hamaguchi, Takao Kojima, Kazuteru Mitsuhashi, Yoshitaka Hashimoto, Akihiro Ohbora, Takahiro Kato, Naoto Nakamura, Michiaki Fukui. Transient remission of nonalcoholic fatty liver disease decreases the risk of incident type 2 diabetes mellitus in Japanese men. European Journal of Gastroenterology & Hepatology 2016; 28(12) doi: 10.1097/MEG.0000000000000736
44
Zi Yuan Zou, Vincent Wai‐Sun Wong, Jian Gao Fan. Epidemiology of nonalcoholic fatty liver disease in non‐obese populations: Meta‐analytic assessment of its prevalence, genetic, metabolic, and histological profiles. Journal of Digestive Diseases 2020; 21(7) doi: 10.1111/1751-2980.12871
45
MITSUYOSHI SUZUKI, SATOSHI NAKANO, YAYOI MURANO, KENICHI MIHARADA. Low Birth Weight Associated with a High Risk of Lifestyle-related Diseases: Fetal Programing During the Developmental Stage. Juntendo Medical Journal 2021; 67(6) doi: 10.14789/jmj.JMJ21-0020-R
46
Vimala Ananthy, Raman Palanyswamy Priyadharsini, Umamaheswari Subramanian. Pathogenesis, Diagnosis, and Management of Metabolic Syndrome: A Comprehensive Review. SBV Journal of Basic, Clinical and Applied Health Science 2021; 4(2) doi: 10.5005/jp-journals-10082-03111
47
Szymon Suwała, Roman Junik. Assessment of the Liver Steatosis and Fibrosis Risk in Metabolic Syndrome and Its Individual Components, Considering the Varying Definitions Used in Clinical Practice throughout Time: A Retrospective Cross-Sectional Study. Biomedicines 2024; 12(8) doi: 10.3390/biomedicines12081739
48
Xiaoping Liu, Ping Yuan, Ying Huang. Association between atherosclerosis-related indicators and fatty liver: a population-based observational study. European Journal of Medical Research 2025; 30(1) doi: 10.1186/s40001-025-03429-y
49
Takuya Fukuda, Masahide Hamaguchi, Takao Kojima, Yasuhiro Ohshima, Akihiro Ohbora, Takahiro Kato, Naoto Nakamura, Michiaki Fukui. Association between serum γ-glutamyltranspeptidase and atherosclerosis: a population-based cross-sectional study. BMJ Open 2014; 4(10) doi: 10.1136/bmjopen-2014-005413
50
Iqbal M. Lone, Fuad A. Iraqi. Genetics of murine type 2 diabetes and comorbidities. Mammalian Genome 2022; 33(3) doi: 10.1007/s00335-022-09948-x
51
Panyavee Pitisuttithum, Wah Kheong Chan, Panida Piyachaturawat, Kento Imajo, Atsushi Nakajima, Yosuke Seki, Kazunori Kasama, Satoru Kakizaki, Jian Gao Fan, Myeong Jun Song, Seung Kew Yoon, Yock Young Dan, Laurentius Lesmana, Khek Yu Ho, Khean Lee Goh, Vincent Wai Sun Wong, Sombat Treeprasertsuk. Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01240-z
52
Herath Mudiyanselage Meththananda Herath, Iroshani Kodikara, Thilak Priyantha Weerarathna, Gayani Liyanage. Prevalence and associations of non-alcoholic fatty liver disease (NAFLD) in Sri Lankan patients with type 2 diabetes: A single center study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(1) doi: 10.1016/j.dsx.2018.09.002
53
Kazuhiko HANASHIRO, Jun MOTOMURA, Masanori SUNAGAWA. Association Between Liver Steatosis and Single Nucleotide Polymorphisms in the <i>PNPLA3</i> Gene in the Northern Part of Okinawa, Japan. JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE 2022; 71(4) doi: 10.2185/jjrm.71.309
54
Yuta Yoshimura, Masahide Hamaguchi, Yoshitaka Hashimoto, Takuro Okamura, Naoko Nakanishi, Akihiro Obora, Takao Kojima, Michiaki Fukui. Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01893-4
55
Alejandra Pérez-Montes de Oca, María Teresa Julián, Guillem Pera, Llorenç Caballería, Rosa Morillas, Pere Torán, Carmen Expósito, Josep Franch-Nadal, Didac Mauricio, Nuria Alonso. Dysglycemia in young women attenuates the protective effect against fatty liver disease. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.971864
56
Amedeo Lonardo, Simona Leoni, Khalid A. Alswat, Yasser Fouad. History of Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2020; 21(16) doi: 10.3390/ijms21165888
57
V. P. Gomonova, A. Yu. Baranovsky, I. S. Sakeian. Honey preparation in complex therapy of metabolically associated fatty liver disease. Experimental and Clinical Gastroenterology 2024; (10) doi: 10.31146/1682-8658-ecg-230-10-195-205
58
Zhenxin Zhu, Yanxun Liu, Chengqi Zhang, Zhongshang Yuan, Qian Zhang, Fang Tang, Haiyan Lin, Yongyuan Zhang, Longjian Liu, Fuzhong Xue, Weiqing Han. Identification of Cardiovascular Risk Components in Urban Chinese with Metabolic Syndrome and Application to Coronary Heart Disease Prediction: A Longitudinal Study. PLoS ONE 2013; 8(12) doi: 10.1371/journal.pone.0084204
59
Naoki Yamamoto, Shin Urai, Masaaki Yamamoto, Masaki Suzuki, Yasutaka Tsujimoto, Hironori Bando, Yuma Motomura, Yuka Ohmachi, Yuriko Sasaki, Yuka Oi-Yo, Michiko Takahashi, Genzo Iguchi, Hidenori Fukuoka, Wataru Ogawa. Body mass index and metabolic complications in individuals with treatment-naïve acromegaly. Endocrine Journal 2025; 72(9) doi: 10.1507/endocrj.EJ25-0047
60
Yiwen Shi, Qianyi Wang, Yameng Sun, Xinyan Zhao, Yuanyuan Kong, Xiaojuan Ou, Jidong Jia, Shanshan Wu, Hong You. The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease. Journal of Clinical Gastroenterology 2020; 54(4) doi: 10.1097/MCG.0000000000001270
61
In Chul Nam, Jung Hee Yoon, Seung Ha Park, JiHwa Ryu, Seung Ho Kim, Yedaun Lee. Association of non-alcoholic fatty liver disease with renal stone disease detected on computed tomography. European Journal of Radiology Open 2016; 3 doi: 10.1016/j.ejro.2016.07.004
62
Breann E Abernathy, Tonya C Schoenfuss, Allison S Bailey, Daniel D Gallaher. Polylactose Exhibits Prebiotic Activity and Reduces Adiposity and Nonalcoholic Fatty Liver Disease in Rats Fed a High-Fat Diet. The Journal of Nutrition 2021; 151(2) doi: 10.1093/jn/nxaa376
63
Sakura Mashiki, Natsuki Matsuoka, Yuri Urakawa, Naohiro Osada, Yuki Hirashima, Kohei Fujiki, Takatoshi Ogami, Tomoyasu Kamiya, Kinya Takagaki, Yoshitaka Iwama. Efficacy Confirmatory Study of Foods Containing <i>Garcinia </i><i>indica</i> Extract on Liver Function: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study. Food and Nutrition Sciences 2025; 16(09) doi: 10.4236/fns.2025.169069
64
Yoshitaka Hashimoto, Masahide Hamaguchi, Takuya Fukuda, Akihiro Ohbora, Takao Kojima, Michiaki Fukui. Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals. Endocrine 2017; 57(1) doi: 10.1007/s12020-017-1313-6
65
Doha Reda. Narrative review of metabolic syndrome and its relationships with non-alcoholic fatty liver disease, gonadal dysfunction and obstructive sleep apnea. Diabetology & Metabolic Syndrome 2025; 17(1) doi: 10.1186/s13098-025-01903-5
66
Harry G. Preuss, Gilbert R. Kaats, Nate Mrvichin, Anand Swaroop, Debasis Bagchi, Dallas Clouatre, Jeffrey M. Preuss. Examining the Relationship Between Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome in Nondiabetic Subjects. Journal of the American College of Nutrition 2018; 37(6) doi: 10.1080/07315724.2018.1443292
67
Liang Wang. Ultrasound-Diagnosed Nonalcoholic Fatty Liver Disease Independently Predicts a Higher Risk of Developing Diabetes Mellitus in Nonoverweight Individuals. Academic Radiology 2019; 26(7) doi: 10.1016/j.acra.2018.08.019
68
Keishi Ichikawa, Toru Miyoshi, Mitsutaka Nakashima, Takahiro Nishihara, Kazuhiro Osawa, Takashi Miki, Hironobu Toda, Masatoki Yoshida, Hiroshi Ito. Prognostic value of pericoronary adipose tissue attenuation in patients with non-alcoholic fatty liver disease with suspected coronary artery disease. Heart and Vessels 2022; 37(12) doi: 10.1007/s00380-022-02107-x
69
Sabine Siegert, Zhonghao Yu, Rui Wang-Sattler, Thomas Illig, Jerzy Adamski, Jochen Hampe, Susanna Nikolaus, Stefan Schreiber, Michael Krawczak, Michael Nothnagel, Ute Nöthlings, Erica Villa. Diagnosing Fatty Liver Disease: A Comparative Evaluation of Metabolic Markers, Phenotypes, Genotypes and Established Biomarkers. PLoS ONE 2013; 8(10) doi: 10.1371/journal.pone.0076813
70
Masashi Hirooka, Yohei Koizumi, Kotarou Sunago, Yoshiko Nakamura, Kana Hirooka, Takao Watanabe, Osamu Yoshida, Yoshio Tokumoto, Masanori Abe, Yoichi Hiasa. Efficacy of B-mode ultrasound-based attenuation for the diagnosis of hepatic steatosis: a systematic review/meta-analysis. Journal of Medical Ultrasonics 2022; 49(2) doi: 10.1007/s10396-022-01196-5
71
Takashi Yamaguchi, Katsunori Yoshida, Miki Murata, Kanehiko Suwa, Koichi Tsuneyama, Koichi Matsuzaki, Makoto Naganuma. Smad3 Phospho-Isoform Signaling in Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences 2022; 23(11) doi: 10.3390/ijms23116270
72
Kazushi Numata. On the occasion of publication of the feature on diagnosis and assessment of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis using ultrasound elastography. Journal of Medical Ultrasonics 2020; 47(4) doi: 10.1007/s10396-020-01060-4
73
Tanya Mohammadi, Babak Mohammadi. Screening the General Population for Non-Alcoholic Fatty Liver Disease: Model Development and Validation. Archives of Medical Research 2024; 55(3) doi: 10.1016/j.arcmed.2024.102987
74
Takuya Fukuda, Masahide Hamaguchi, Takao Kojima, Yoshitaka Hashimoto, Akihiro Ohbora, Takahiro Kato, Naoto Nakamura, Michiaki Fukui. The impact of non‐alcoholic fatty liver disease on incident type 2 diabetes mellitus in non‐overweight individuals. Liver International 2016; 36(2) doi: 10.1111/liv.12912
75
Kimiko Sakai, Takuro Okamura, Ema Toyokuni, Hiroshi Okada, Akihiro Obora, Takao Kojima, Masahide Hamaguchi, Michiaki Fukui. Metabolic dysfunction‐associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study. Journal of Diabetes Investigation 2024; 15(12) doi: 10.1111/jdi.14315
76
M. Zhao, Y. Hu, C. Shi, K. Wang, J. Li, J. Song, C. Huo, Y. Xi, S. Bu, Q. Huang. NFI, a clinical scoring tool for predicting non-alcoholic fatty liver in the Chinese population. Public Health 2022; 202 doi: 10.1016/j.puhe.2021.10.012
77
Masayuki Ueno, Takahisa Kayahara, Hiroyuki Takabatake, Youichi Morimoto, Motowo Mizuno. Clinical characteristics and diagnostic process of nonalcoholic fatty liver disease-associated hepatocellular carcinoma. Kanzo 2023; 64(3) doi: 10.2957/kanzo.64.122
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.